(NASDAQ: CODX) Co Diagnostics's forecast annual revenue growth rate of 613.35% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.71%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.09%.
Co Diagnostics's revenue in 2026 is $507,892.On average, 4 Wall Street analysts forecast CODX's revenue for 2026 to be $1,192,520, with the lowest CODX revenue forecast at $1,098,015, and the highest CODX revenue forecast at $1,278,744. On average, 3 Wall Street analysts forecast CODX's revenue for 2027 to be $35,581,570, with the lowest CODX revenue forecast at $34,185,100, and the highest CODX revenue forecast at $36,626,893.
In 2028, CODX is forecast to generate $438,264,268 in revenue, with the lowest revenue forecast at $421,072,260 and the highest revenue forecast at $451,153,199.